NCT01658436 2016-05-02BEZ235 Phase II Trial in Patients With Advanced Pancreatic Neuroendocrine Tumors (pNET) After Failure of mTOR Inhibitor Therapy.NovartisPhase 2 Completed31 enrolled 7 charts
NCT01628913 2016-04-07Efficacy and Safety of BEZ235 Compared to Everolimus in Patients With Advanced Pancreatic Neuroendocrine TumorsNovartisPhase 2 Terminated62 enrolled 7 charts
NCT01453595 2016-02-29BEZ235 in Patients With Advanced Renal Cell Carcinoma (RCC)Memorial Sloan Kettering Cancer CenterPhase 1/2 Terminated10 enrolled 8 charts